Nutex Health Inc. NUTX
Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2011-03-18
Nutex Health Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $331.5M |
| Gross profit | $444.3M | $196.3M | $34.8M | $15.4M | $179.3M |
| R&D expense | — | — | — | — | $285,880 |
| Operating income | $275.6M | $130.7M | -$31.8M | -$406.6M | $170.3M |
| Interest expense | — | — | $16.3M | $12.5M | $6.2M |
| Income tax | $64.4M | $15.0M | -$5.1M | $13.1M | $965,731 |
| Net income | $70.8M | $52.1M | -$45.8M | -$424.8M | $132.6M |
| EPS (diluted) | $10.48 | $9.69 | $-10.39 | $-100.36 | $0.22 |
| Operating cash flow | $248.1M | $23.2M | $1.3M | $50.6M | $173.4M |
| Free cash flow | $245.6M | $20.8M | -$8.2M | $36.0M | $136.5M |
| Cash & equivalents | $185.6M | $40.6M | $22.0M | $34.3M | $36.1M |
| Inventory | $2.9M | $2.9M | $3.4M | $3.5M | $2.8M |
| Total assets | $918.5M | $655.3M | $398.2M | $431.8M | $394.7M |
| Total liabilities | $495.1M | $466.8M | $319.1M | $311.4M | $203.1M |
| Shareholders' equity | $423.4M | $188.5M | $79.1M | $120.3M | $191.6M |
Source: SEC EDGAR filings · CIK 0001479681 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.